Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P43
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.34% |
| Q3 2025 | 6.35% |
| Q2 2025 | -5.02% |
| Q1 2025 | -24.70% |
| Q4 2024 | 65.89% |
| Q3 2024 | -23.07% |
| Q2 2024 | 41.98% |
| Q1 2024 | -14.49% |
| Q4 2023 | -2.73% |
| Q3 2023 | -12.24% |
| Q2 2023 | 3.71% |
| Q1 2023 | -14.20% |
| Q4 2022 | 16.95% |
| Q3 2022 | -11.95% |
| Q2 2022 | -12.13% |
| Q1 2022 | -9.80% |
| Q4 2021 | -9.81% |
| Q3 2021 | -6.86% |
| Q2 2021 | 375.63% |
| Q1 2021 | -12.11% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |